SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Abroad (travel likely)RecruitingPHASE3

Conditions

Glioma · Astrocytoma, Grade IV · IDH1-mutant Glioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4 · Astrocytoma, IDH-Mutant, Grade 2 · Oligodendroglioma · Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama, Birmingham, Alabama, United States
Contact: Study coordinator (Shirley Gibbs) · sgibbs@uabmc.edu · 205-975-0447
Contact: Principal Investigator (Luis Nabors, MD)
Mayo Clinic - Arizona, Phoenix, Arizona, United States
Contact: Study coordinator (MCC Prep Team) · mccprepteam@mayo.edu · 904-956-8227
Contact: Principal Investigator (Shannon Fortin Ensign, MD)
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Contact: Study coordinator (Sandra Arenas) · sandra.arenas@commonspirit.org · 602-406-3823
Contact: Principal Investigator (Yoshie Umemura, MD)
University of California San Diego, La Jolla, California, United States
Contact: Study coordinator (Sheila Medina-Torne) · s4medina@health.ucsd.edu · 858-246-1093
Contact: Principal Investigator (David Piccioni, MD)
University of California, Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Quan Li) · quanli@mednet.ucla.edu · 310-206-6909
Study coordinator · 310-206-6909
Contact: Principal Investigator (Robert Chong, MD)
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Study coordinator (Jason Ledesma) · jason.ledesma@hoag.org · 949-764-2794
Contact: Principal Investigator (Simon Khagi, MD)
Stanford University, Palo Alto, California, United States
Contact: Study coordinator (Sahara Rout) · ssrout@stanford.edu · 650-723-4467
Contact: Principal Investigator (Seema Nagpal, MD)
University of California, San Francisco, California, United States
Contact: Study coordinator (Neuro Onc New Patient Coordinator) · neurooncnewpatientcoord@ucsf.edu · 415-353-2193
Contact: Principal Investigator (John De Groot, MD)
University of Colorado Health Cancer Care, Aurora, Colorado, United States
Contact: Study coordinator (Stephanie Biller) · stephanie.biller@cuanschutz.edu · 720-848-2080
Contact: Principal Investigator (Denise Damek, MD)
Yale University, New Haven, Connecticut, United States
Contact: Study coordinator (Amy Rodrigues) · amy.rodrigues@yale.edu · 203-737-7084
Contact: Principal Investigator (Nicholas Blondin, MD)
University of Florida Health, Gainesville, Florida, United States
Contact: Study coordinator (Victoria Hope) · victoria.hope@neurosurgery@ufl.edu · 352-273-9000
Contact: Principal Investigator (Ashley Ghiaseddin, MD)
Mayo Clinic - Florida, Jacksonville, Florida, United States
Contact: Study coordinator (Mayo Clinic Mailbox) · mcccprepteam@mayo.edu · 904-953-0856
Contact: Principal Investigator (Wendy Sherman, MD)
University of Miami Health, Miami, Florida, United States
Contact: Study coordinator (Irene Marino) · idm32@med.miami.edu · 305-243-2858
Contact: Principal Investigator (Macarena de la Fuente, MD)
Orlando Health Cancer Institute, Orlando, Florida, United States
Contact: Study coordinator (Janice Porter) · janice.porter@orlandohealth.com · 321-841-7246
Contact: Principal Investigator (Alfredo Voloschin, MD)
University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Lauren Singer) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-1000
Contact: Principal Investigator (Lauren Singer, MD)
Indiana University, Indianapolis, Indiana, United States
Contact: Study coordinator (Jennifer Terrell) · jkramey@iu.edu · 317-278-6266
Contact: Principal Investigator (Kathryn Nevel, MD)
University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Study coordinator (Clinical Trial Nurse Navigator) · CTNurseNav@kumc.edu · 913-945-7552
Contact: Principal Investigator (Tolga Tuncer, MD)
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Julie Miller) · julie.miller@mgh.harvard.edu · 866-493-1612
Contact: Principal Investigator (Julie Miller, M.D.)
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Amanda Dresser) · amanda_dresser@dfci.harvard.edu · 877-338-7425
Contact: Principal Investigator (David Reardon, MD)
Henry Ford Hospital, Detroit, Michigan, United States
Contact: Study coordinator (Phillip Alther) · palther1@hfhs.org · 313-651-1606
Contact: Principal Investigator (Tobias Walbert, MD)
Mayo Clinic - Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Sonia Velazquez) · mcccprepteam@mayo.edu · 507-293-3564
Contact: Principal Investigator (Eva Galanis, MD)
Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Leslie Nehring) · lnehring@wustl.edu · 314-830-8120
Contact: Principal Investigator (Omar Butt, MD)
Billings Clinic, Billings, Montana, United States
Contact: Study coordinator (Department of Neurology and Oncology Cancer Research) · cancerresearch@billingsclinic.org · 406-435-7480
Contact: Principal Investigator (Matthew Smith-Cohn, MD)
Rutgers Cancer Institute, New Brunswick, New Jersey, United States
Contact: Study coordinator (Simbiat Ajao) · ajao@cinj.rutgers.edu · 732-235-7503
Contact: Principal Investigator (Morana Vojnic, MD)
NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Olga Garduno-Ortega) · olga.garduno-ortega@nyulangone.org · 212-731-6267
Contact: Principal Investigator (Jose McFaline-Figueroa, MD)
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Camila Tanlam) · camila.tanlam@mountsinai.org · 646-315-3698
Contact: Study coordinator (Suzette Dayes-Mays) · suzette.dayes-mays@mountsinai.org · 646-531-4350
Contact: Principal Investigator (Kim Lydon, MD)
Columbia University Medical Center, New York, New York, United States
Contact: Study coordinator (Research Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162
Contact: Principal Investigator (Fabio Iwamoto, MD)
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Nancy Keith) · keithn@mskcc.org · 347-971-3051
Contact: Study coordinator (Madeleine Ruff) · RuffM@mskcc.org
Contact: Principal Investigator (Thomas Kaley, M.D.)
University of Rochester Medical Center, Rochester, New York, United States
Contact: Study coordinator (Nimish Mohile, MD) · nimish_mohile@urmc.rochester.edu · 585-275-4401
Contact: Principal Investigator (Nimish Mohile, MD)
Duke Cancer Institute, Durham, North Carolina, United States
Contact: Study coordinator (Erin Severance) · erin.k.bell@duke.edu · (919) 668-6230
Contact: Principal Investigator (Katy Peters, M.D.)
Cleveland Clinic, Cleveland, Ohio, United States
Contact: Study coordinator (Marci Ciolfi) · ciolfim@ccf.org · 216-445-3307
Contact: Principal Investigator (Mina Lobbous, M.D.)
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Community Research Operations & Enrollment (CROE) · onctrialnow@jefferson.edu · 251-600-9151
Contact: Principal Investigator (Iyad Alnahhas, MD)
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Linda Elias) · eliaslj@upmc.edu · 412-623-6037
Contact: Principal Investigator (Michal Nisnboym Ziv, MD)
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Study coordinator (Vanderbilt-Ingram Cancer Center) · cip@vumc.org · 1-800-811-8480
Contact: Principal Investigator (Ryan Merrell, MD)
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Omar Raslan) · omar.raslan@utsouthwestern.edu · 214-645-2616
Contact: Principal Investigator (Michael Youssef, MD)
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Eva Gachimova) · egachimova@mdanderson.org · 713-792-2883
Contact: Principal Investigator (Vinay Puduvalli, MD)
Mays Cancer Center, San Antonio, Texas, United States
Contact: Study coordinator (Leti Velten) · velten@uthscsa.edu · 210-450-1921
Contact: Principal Investigator (Andrew Brenner, MD)
Huntsman Cancer Insititute, University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Neuro Oncology Coordination) · neurooncologycoordinationsstaff@hci.utah.edu · 801-585-0115
Contact: Principal Investigator (Howard Colman, MD)
UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville, Virginia, United States
Contact: Study coordinator (CJ Woodburn, 434-243-9900) · cjw4v@virginia.edu
Contact: Principal Investigator (David Schiff, M.D.)
Inova Schar Cancer Institute, Fairfax, Virginia, United States
Contact: Study coordinator (Stephanie Van Bebber) · stephanie.vanbebber@inova.org · 571-472-4724
Contact: Principal Investigator (Adam Cohen, MD)
Fred Hutch Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Madhuri Poduri) · mpoduri@fredhutch.org · 206-667-3691
Contact: Principal Investigator (Vyshak Venur, MD)
University of Wisconsin Health, Madison, Wisconsin, United States
Contact: Study coordinator (UW Cancer Connect) · cancerconnect@uwhealth.org · 800-622-8922
Contact: Principal Investigator (Ankush Bhatia, MD)
St Vincents Hospital Sydney (Kinghorn), Darlinghurst, New South Wales, Australia
Contact: Study coordinator (Ashley Douglas) · ashley.douglas@svha.org.au · 02 9355 5613
Contact: Principal Investigator (Subotheni Thavaneswaran, MD)
Royal North Shore Hospital, Saint Leonards, New South Wales, Australia
Contact: Study coordinator (Sally McCowatt) · sally.mccowatt@health.nsw.gov.au · 02 9463 1181
Contact: Principal Investigator (Helen Wheeler, MD)
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Contact: Study coordinator (Amy Ives) · Amy.Ives@health.qld.gov.au · 07 3646 7712
Contact: Principal Investigator (Zarnie Lwin, MD)
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (Clinical Trial Team (Monc A Team) · PCCTU.MoncA@petermac.org · (03) 8559 5000
Contact: Principal Investigator (Jim Whittle, MD)
The Alfred, Melbourne, Victoria, Australia
Contact: Study coordinator (Lucy Gately, MD) · l.gately@alfred.org.au · 03 9076 3129
Contact: Principal Investigator (Lucy Gately, MD)
Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
Contact: Study coordinator (Wee Chin, MD) · wee.chin@health.wa.gov.au · 61 6457 3333
Contact: Principal Investigator (Wee Chin, MD)
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Xiaohui Ren, MD) · xiaohuiren@aliyun.com · 15011450618
Contact: Principal Investigator (Xiaohui Ren, MD)
Sanbo Brain Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Junping Zhang, MD) · doczhjp@hotmail.com · 13811099759
Contact: Principal Investigator (Junping Zhang, MD)
Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Qingtang Lin, MD) · linqingtang@xwhosp.org · 15801588169
Contact: Principal Investigator (Qingtang Lin, MD)
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Wenbin Ma, MD) · mawb@pumch.cn · 13701364566
Contact: Principal Investigator (Wenbin Ma, MD)
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Contact: Study coordinator (Dezhi Kang, MD) · kdz99988@sina.com · 0591-87982123
Contact: Principal Investigator (Dezhi Kang, MD)
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Zhongping Chen, MD) · chenzhp@sysucc.org.cn · 020-87343310
Contact: Principal Investigator (Zhongping Chen, MD)
Xiangya Hospital of Central South University, Changsha, Hunan, China
Contact: Study coordinator (Zhixiong Liu, MD) · zhixiongliu@csu.edu.cn · 13607318785
Contact: Principal Investigator (Zhixiong Liu, MD)
Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Ying Mao, MD) · my_gcp@sina.com · 13801769152
Contact: Principal Investigator (Ying Mao, MD)
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Yanhui Liu, MD) · liuyh@scu.edu.com · 18980601509
Contact: Principal Investigator (Yanhui Liu, MD)

View source on ClinicalTrials.gov